Market News
Stay updated with the latest market trends, earnings, and economic indicators.
HCG uses AI, patient data to personalise cancer treatment: BS Ajaikumar, founder
Healthcare Global Enterprises is using artificial intelligence and patient data. Algorithms are being developed to personalise cancer treatment and improve outcomes. The company analyses clinical and genomic data to classify patients for better decisions. HCG partnered with Accenture to enhance its AI research capabilities.
Blue Jet Healthcare shares rally 9% after Rs 800 crore QIP allotment
Blue Jet Healthcare shares rose sharply on Friday after the company completed its Rs 800 crore QIP, attracting marquee institutional investors, including multiple ICICI Prudential Mutual Fund schemes. The fund raise is expected to strengthen the company's balance sheet, support expansion plans, and boost long-term growth prospects while broadening its institutional shareholder base.
Blue Jet Healthcare Shares Surge Over 8% After Rs 800 Crore QIP Allotment
Blue Jet Healthcare shares surged over 8%
Blue Jet Healthcare raises ₹800 crore via QIP, two institutions get nearly 67% of shares
At the end of the June quarter, promoters and promoter groups of Blue Jet Healthcare held 79.81% stake in the company, as per data available on the exchanges, while public shareholders held a 20.19% stake.
Cobra India acquires 2.05% stake in Sakar Healthcare via open market - scanx.trade
Cobra India acquires 2.05% stake in Sakar Healthcare via open marketscanx.trade
IKS Health completes acquisition of TruBridge, Inc.
IKS Health announced the successful completion of its previously announced acquisition of TruBridge, Inc. TruBridge is a prominent provider of healthcare technology including an electronic health record (EHR) and revenue cycle management solutions for rural and community hospitals. Following the closing, TruBridge operates as a wholly owned subsidiary of IKS Health.
IHH hospitals in India, Singapore saw fewer patients from Middle East due to war
IHH Healthcare hospitals in India saw fewer patients from the UAE and Saudi Arabia. Singapore hospitals also faced impacts from the ongoing Middle East conflict. This regional instability creates significant uncertainty for businesses globally. Soaring energy prices and disrupted supply chains are major concerns. IHH previously stated its diversified footprint mitigated earlier geopolitical impacts.
Cupid rebounds 6% after sharp fall as upgraded FY27 guidance boosts sentiment
Cupid shares rebounded nearly 6% after a sharp correction in the previous session, as investors turned positive following the company’s upgraded FY27 revenue guidance of Rs 660 crore. Strong Q1 momentum, a robust order book, expanding global opportunities, and growth across healthcare, personal care, and wellness businesses helped revive sentiment toward the stock.
Stocks to Watch today: TCS, Tata Steel, GMR Airports, M&M, SBI, HFCL & more
Stocks to watch today: TCS, SBI, Tata Steel, GMR Airports, M&M, HFCL, RIL, Fortis Healthcare, JSW Infra, Swiggy, Pidilite, Shree Cement, among others, will be in focus today
Why is Alignment Healthcare stock sliding today? By Investing.com - Investing.com India
Why is Alignment Healthcare stock sliding today? By Investing.comInvesting.com India
Opportunity worth $35 billion for medtech sector in India by 2030: Bain & Co
India's medtech sector presents a USD 35 billion opportunity by 2030. Exports are projected to reach USD 8 billion, growing over twenty percent annually. The nation is becoming a prominent access-led innovator in the Asia-Pacific region. This growth is driven by increasing healthcare demand and a developing innovation ecosystem. India's medical device exports reached USD 4 billion in FY25.
Fortis Healthcare board okays extending MD & CEO Ashutosh Raghuvanshi's tenure by 2 years
Fortis Healthcare's board has approved Ashutosh Raghuvanshi's reappointment as Managing Director. His new term will commence on March 19, 2027, for a period of two years. This reappointment follows the conclusion of his current tenure on March 18, 2027. The board cited his expertise and role in the company's growth for this decision.